Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Pottier

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 4, 2017
Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phaseJean-Baptiste Gibier, Brigitte Hémon, Mélanie Fanchon, et al.
Biochemical Pharmacology|May 28, 2004
Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter regionChristelle Cauffiez, Florian Klinzig, Emmanuel Rat, et al.
Plos Medicine|April 18, 2008
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profileMichael J Sorich, Nicolas Pottier, Deqing Pei, et al.
Journal of the National Cancer Institute|December 11, 2008
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemiaNicolas Pottier, Wenjian Yang, Mahfoud Assem, et al.
Cancer Letters|January 4, 2014
MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoterViviane Gnemmi, Audrey Bouillez, Kelly Gaudelot, et al.
Oncotarget|February 8, 2014
MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathwayAudrey Bouillez, Viviane Gnemmi, Kelly Gaudelot, et al.
British Journal of Haematology|September 29, 2012
Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) studyPauline Peyrouze, Soizic Guihard, Nathalie Grardel, et al.
Journal of Personalized Medicine|October 23, 2021
Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective StudyRémi Lenain, Mehdi Maanaoui, Aghilès Hamroun, et al.
Pharmacogenomics|December 19, 2014
Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipientsJulie Bloch, Marc Hazzan, Cynthia Van der Hauwaert, et al.
Cells|August 7, 2021
The FibromiR miR-214-3p Is Upregulated in Duchenne Muscular Dystrophy and Promotes Differentiation of Human Fibro-Adipogenic Muscle ProgenitorsNicole Arrighi, Claudine Moratal, Grégoire Savary, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 4, 2017
Dual role of MUC1 mucin in kidney ischemia-reperfusion injury: Nephroprotector in early phase, but pro-fibrotic in late phaseJean-Baptiste Gibier, Brigitte Hémon, Mélanie Fanchon, et al.
Biochemical Pharmacology|May 28, 2004
Functional characterization of genetic polymorphisms identified in the human cytochrome P450 4F12 (CYP4F12) promoter regionChristelle Cauffiez, Florian Klinzig, Emmanuel Rat, et al.
Plos Medicine|April 18, 2008
In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profileMichael J Sorich, Nicolas Pottier, Deqing Pei, et al.
Journal of the National Cancer Institute|December 11, 2008
The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemiaNicolas Pottier, Wenjian Yang, Mahfoud Assem, et al.
Cancer Letters|January 4, 2014
MUC1 drives epithelial-mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoterViviane Gnemmi, Audrey Bouillez, Kelly Gaudelot, et al.
Oncotarget|February 8, 2014
MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathwayAudrey Bouillez, Viviane Gnemmi, Kelly Gaudelot, et al.
British Journal of Haematology|September 29, 2012
Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) studyPauline Peyrouze, Soizic Guihard, Nathalie Grardel, et al.
Journal of Personalized Medicine|October 23, 2021
Impact of Tacrolimus Daily Dose Limitation in Renal Transplant Recipients Expressing CYP3A5: A Retrospective StudyRémi Lenain, Mehdi Maanaoui, Aghilès Hamroun, et al.
Pharmacogenomics|December 19, 2014
Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipientsJulie Bloch, Marc Hazzan, Cynthia Van der Hauwaert, et al.
Cells|August 7, 2021
The FibromiR miR-214-3p Is Upregulated in Duchenne Muscular Dystrophy and Promotes Differentiation of Human Fibro-Adipogenic Muscle ProgenitorsNicole Arrighi, Claudine Moratal, Grégoire Savary, et al.
Pageof 7